Tenet Healthcare Corporation — FY2010 Form 10-K
Reporting period: Fiscal year ended December 31, 2010. The filing also reports fourth-quarter results for the three months ended December 31, 2010. Unless noted, financial amounts are in millions of dollars.
Business context
Tenet operates acute-care hospitals and related health care businesses. At year-end it operated 49 general hospitals and one critical-access hospital, with 13,428 licensed beds across 11 states, plus outpatient centers and Conifer revenue-cycle services. General hospitals generated 97.4% of annual net operating revenue.
Key financial metrics
| Metric | FY2010 | FY2009 |
|---|---|---|
| Net operating revenues | $9,205 | $9,014 |
| Operating income | $634; 6.9% margin | $538; 6.0% margin |
| Income from continuing operations, after tax | $1,135 | $228 |
| Net income attributable to common shareholders | $1,119 | $181 |
| Diluted EPS from continuing operations | $2.01 | $0.43 |
| Adjusted EBITDA (non-GAAP) | $1,050; 11.4% margin | $982; 10.9% margin |
| Cash provided by operating activities | $472 | $425 |
| Adjusted free cash flow (non-GAAP) | $92 | $122 |
Fourth-quarter net operating revenue was $2,301 versus $2,261 in Q4 2009. Net income attributable to common shareholders was $74 versus $21; diluted EPS was $0.14 versus $0.04. The filing’s quarterly table does not provide a clear Q4 operating-income or margin value.
At December 31, cash and cash equivalents were $405 (versus $690 a year earlier); working capital was $586 (versus $689); total assets were $8,500; and total equity was $1,819 (versus $697). Long-term debt, including current maturities, was $4,064; the balance-sheet long-term portion was $3,997. The company reported $507 of borrowing availability under its $800 revolving facility, with no cash borrowings outstanding and $181 of letters of credit. Net debt to last-12-month Adjusted EBITDA was 3.5x.
Changes versus prior comparable period
- Annual revenue increased 2.1%, while admissions fell 2.4%, patient days fell 3.1%, and outpatient visits fell 0.4%. Pricing, higher acuity, managed-care contract improvements, and outpatient growth supported revenue despite lower volumes.
- Net inpatient revenue increased 0.5%; net outpatient revenue rose 4.8%. Annual operating income rose $96, and operating margin improved 0.9 percentage point.
- Provision for doubtful accounts rose to $740 from $697, or 8.0% of revenue versus 7.7%. Self-pay collection rates declined to 28.3% from 30.1%; managed-care collection rates were 98.4% versus 98.0%.
- Operating cash flow increased $47, but adjusted free cash flow declined $30, reflecting increased capital spending and other factors. Capital expenditures were $476 versus $456.
- Debt was reduced from $4,274 to $4,064 at year-end. The company issued $600 of 8% notes due 2020 and repurchased approximately $782 principal amount of 7⅜% notes due 2013, recording a $57 loss on early extinguishment of debt for the year.
Outlook, management commentary, risks and unusual items
- Earnings quality: The $977 income-tax benefit was primarily driven by a roughly $1.06 billion reduction in the deferred-tax-asset valuation allowance, based on management’s assessment of future taxable income. This non-cash accounting benefit substantially boosted reported earnings; it is not equivalent to recurring operating profit.
- Outlook: Management provided no specific earnings or revenue guidance. It forecast 2011 continuing-operations capital expenditures of approximately $475–$525, including accrued amounts. It expected to begin receiving HIT incentive payments no later than 2012, but estimated HIT investment through 2014 at about $620 and likely incentives of about $320, subject to implementation and eligibility.
- California provider fee: Federal approval was received in January 2011. Tenet estimated approximately $64 of net revenue for the 21-month program, to be recognized in Q1 2011. A proposed six-month extension could yield an estimated $28, but legislation and approval were uncertain.
- Healthcare reform and reimbursement: Management anticipated eventual benefit from expanded coverage, potentially beginning in 2014, but cautioned that Medicare/Medicaid rate and disproportionate-share reductions could offset gains. The company estimated selected 2011 Medicare payment-rule effects, including a roughly $5 annual inpatient revenue decrease and an $8 outpatient increase; estimates are uncertain.
- Operating pressures: Management cited declining patient volumes, weaker commercial managed-care enrollment, competition, economic pressures, high bad debt, labor and nursing costs, and payer-mix shifts. Managed care represented 56.5% of net patient revenue; Medicare 23.9% and Medicaid 8.7%.
- Debt and liquidity: Debt service, covenant restrictions, refinancing needs, and reliance on operating cash flow remain material considerations. The 2015 note maturity could accelerate the revolving facility expiration if specified refinancing conditions are not met. Management said current liquidity sources should cover current needs, while longer-term debt service depends on improved cash flow and favorable financing markets.
- Legal and regulatory matters: Government reviews covered rehabilitation admissions, kyphoplasty billing, a Florida partial-hospitalization program, and ICD implant procedures; Tenet reported $27 of reserves for governmental reviews and said outcomes and timing were uncertain. Katrina-related class actions, medical-malpractice matters, and other claims also remain. Six shareholder suits followed Community Health Systems’ unsolicited $6-per-share acquisition proposal; Community also launched a board proxy contest. Tenet’s board rejected the proposal.
- Other exposures: Approximately 20% of facility employees were union-represented, with contract negotiations and possible organizing activity. California seismic compliance was estimated at $31 total, of which $27 had been spent; disability-access improvements were expected to require another $98 over five years. NOL use may be limited by ownership changes under Section 382; Tenet adopted a rights agreement in January 2011.
- Unusual operating item: Q4 2010 other operating expenses included a favorable $10 adjustment related to recovery of certain historical payroll taxes. The 2010 annual impairment and restructuring charge was $10, and litigation/investigation costs were $12. Auditors issued unqualified opinions on the financial statements and internal control over financial reporting.
Most important facts for investors to verify
- How much of reported FY2010 earnings reflects the deferred-tax valuation-allowance release, and what assumptions support future taxable income and NOL realization?
- Whether admissions and self-pay collection trends stabilize, and whether revenue-per-case improvements can offset lower volumes and bad debt.
- Actual cash generation after capital expenditures, 2011 capital spending, and progress toward reducing leverage and refinancing maturities.
- Final California provider-fee proceeds and any extension, together with the net impact of health reform and Medicare/Medicaid reimbursement changes.
- Developments and potential financial exposure from government reviews, Katrina litigation, shareholder litigation, and the Community Health Systems proposal and proxy contest.